Subscribe
Healthcare

In the right population, hydroxychloroquine works. So why are people still up in arms?

By
Published
Add Washington Examiner on Google
In the right population, hydroxychloroquine works. So why are people still up in arms?

The debate over the use of hydroxychloroquine rages on as COVID-19 cases in the United States exceed 6,000,000 and deaths approach 200,000.

From many respected corners of the medical and regulatory establishment, we have been led to believe, emphatically, that the case for HCQ is now closed. Many studies are cited as evidence that giving HCQ to COVID-19 patients is, at best, ineffective and, at worst, harmful.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

COVID-19 Health Pharmaceutical Industry